CROs offering Pathology & Histology Services with Gene Therapy
8 published
8 published CROs match Pathology & Histology Services and Gene Therapy.
Locations in this set include United States, China, Belgium, Global, India, and Netherlands.
Capabilities that show up most often in this set: In Vivo Efficacy Models, In Vivo PK / PD Studies, Preclinical In Vivo Studies, Preclinical In Vitro Studies, and Specialized & Large-Animal Models.
Matching companies
Crown BiosciencePreclinical oncology CRO offering 2,500+ PDX models, organoid and cell line databases, and translational platforms with biomarker discovery and AI-driven systems biology for drug development.
Frontage LaboratoriesGlobal pharmaceutical development organization offering integrated drug discovery, preclinical safety/toxicology, DMPK, bioanalytical, and clinical trial services across 28 sites with 2,200 employees and 200+ FDA inspections.
InnoSerInnoSer is a contract research organization based in the Netherlands and Belgium, supporting discovery and preclinical drug development. It offers in vivo and in vitro disease models and GLP toxicology studies.
InotivInotiv provides integrated preclinical and safety assessment services including toxicology, bioanalysis, pathology, and specialized research models across discovery through IND-enabling phases.
LabcorpLabcorp is a global life sciences and healthcare company providing diagnostic testing, drug development, nonclinical research, central laboratory services, and real-world data solutions to healthcare providers, health systems, and biopharma companies.
PharmaronPremier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK.
Syngene InternationalInnovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.
VIRSCIOVirscio is a preclinical CRO offering non-human primate studies, histopathology, and molecular biology services. It supports IND-enabling efficacy, safety, and PK/PD programs in CNS, ophthalmology, and cardiometabolic areas.
Markdown mirror: /explore/pathology-histology/gene-therapy.md